Secondly, hyperinsulinemia exists in most T2DM patients during the early period of diabetes, and might be another potential cancer risk due to its role in biological cell proliferation via the IGF–1 signaling pathway [14]. The gene discussed is IGF1; the disease is diabetes mellitus.